
Abstract Purpose To describe and analyze major local complications after intraoperative radiotherapy (IORT) with low-energy x‑rays during breast-conserving surgery (BCS) in early breast cancer. Methods Ten women out of 408 who were treated with IORT between 2002 and 2017 and subsequently developed a severe local complication requiring surgical intervention were retrospectively identified and analyzed. Demographic, clinical, and surgical parameters as well as complication characteristics and treatment methods were evaluated. Results At initial presentation, eight patients (80%) showed redness, six (60%) seroma, six (60%) wound infection, six (60%) suture dehiscence, and four (40%) induration of the former surgical area. Hematoma and necrosis were observed in one case (10%) each. Time interval until appearance of the first symptoms ranged from directly postoperative until 15 years postoperatively (median 3.1 months). Initial treatment modalities comprised antibiotic therapy (n = 8/80%) and transcutaneous aspiration of seroma (n = 3/30%). In the majority of patients, smaller surgical interventions (excision of a necrotic area/fistula [n = 6/60%] or secondary suture [n = 5/50%]) were sufficient to overcome the complication, yet larger interventions such as complex flap surgery and mastectomy were necessary in one patient each. Conclusion IORT is an efficient and safe treatment method as < 2.5% of all IORT patients experienced major local complications. However, it seems to pose the risk of causing severe local complications that may require lengthy and burdensome treatment. Thorough preoperative counseling, implementation of recommended intraoperative precautions, and high vigilance for first symptoms of complications during follow-up appointments are necessary measures.
Seroma, Intraoperative Care, X-Rays, Humans, Female [MeSH] ; Mastectomy, Segmental [MeSH] ; Humans [MeSH] ; Breast Neoplasms/drug therapy [MeSH] ; Radiotherapy, Adjuvant/adverse effects [MeSH] ; Retrospective Studies [MeSH] ; X-Rays [MeSH] ; Breast-conserving surgery ; Seroma/surgery [MeSH] ; Mastectomy/adverse effects [MeSH] ; Breast Neoplasms/radiotherapy [MeSH] ; Complication ; Original Article ; Wound infection ; Intrabeam ; Partial breast irradiation ; Mastectomy/methods [MeSH] ; Intraoperative Care/adverse effects [MeSH] ; Breast Neoplasms/surgery [MeSH] ; Seroma/etiology [MeSH], Original Article, Female, Breast Neoplasms, Radiotherapy, Adjuvant, Mastectomy, Segmental, Mastectomy, Retrospective Studies
Seroma, Intraoperative Care, X-Rays, Humans, Female [MeSH] ; Mastectomy, Segmental [MeSH] ; Humans [MeSH] ; Breast Neoplasms/drug therapy [MeSH] ; Radiotherapy, Adjuvant/adverse effects [MeSH] ; Retrospective Studies [MeSH] ; X-Rays [MeSH] ; Breast-conserving surgery ; Seroma/surgery [MeSH] ; Mastectomy/adverse effects [MeSH] ; Breast Neoplasms/radiotherapy [MeSH] ; Complication ; Original Article ; Wound infection ; Intrabeam ; Partial breast irradiation ; Mastectomy/methods [MeSH] ; Intraoperative Care/adverse effects [MeSH] ; Breast Neoplasms/surgery [MeSH] ; Seroma/etiology [MeSH], Original Article, Female, Breast Neoplasms, Radiotherapy, Adjuvant, Mastectomy, Segmental, Mastectomy, Retrospective Studies
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 6 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
